Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively “Kessler”) conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) interacts with implanted intrathecal baclofen (ITB) pump delivery systems for managing spasticity. The article, “Transcutaneous spinal stimulation in patients with intrathecal baclofen pump delivery system: A preliminary safety study,” (doi: 10.3389/fnins.2022.1075293), was published December 21, 2022, in Frontiers in Neuroscience. It is available open access at: https://www.frontiersin.org/articles/10.3389/fnins.2022.1075293/full
The pilot study was conducted at the Tim and Caroline Reynolds Center for Spinal Stimulation by John Lopez, DO, Gail Forrest, PhD, Einat Engel-Haber, MD, Brittany Snider, MD, Kam Momeni, PhD, Manikandan Ravi, MS, and Steven Kirshblum, MD.
